Ä¢¹½tvÊÓƵ

Enrolling Adults 60+: Help to see if we can protect people against symptoms caused by the norovirus stomach bug with an investigational mRNA vaccine

Ä¢¹½tvÊÓƵ is looking for participants for the Nova 301 Trial. This trial will see if an investigational vaccine can protect people 60 years of age or older against symptoms caused by the norovirus stomach bug.

Honouring military experience in healthcare

Inhealthcare visit Ä¢¹½tvÊÓƵ Children’s Hospital Oncology Virtual Ward to see digital platform in action

Steve Bush appointed as Chief Clinical Information Officer

Funding boost for radiotherapy in Ä¢¹½tvÊÓƵ to help make faster progress for cancer patients

Celebrating 10 years of giggles at Ä¢¹½tvÊÓƵ Children’s Hospital with a Giggle Doctor Take-Over

Trust collaborates on study to improve lung cancer diagnosis with AI

Fostering clinical excellence through data and collaboration: Partnership with Ledidi

Virtual ward pilot reduces waits for young patients

Trust launches exciting new podcast